Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users

Abstract

Case series Patients: Female, 30-year-old • Female, 30-year-old Final Diagnosis: Serratia marcescens infective endocarditis Symptoms: Chest pain • fever • leukocytosis • murmur Clinical Procedure: — Specialty: Cardiac Surgery • Cardiology • Infectious Diseases • General and Internal Medicine Objective: Unusual clinical course Background: We report 2 cases of recurrent right-sided endocarditis in 2 young patients known to be intravenous (i.v.) drug users. We highlight the importance of early diagnosis and management, especially in recurrent infection, which has a higher mortality rate and poor prognostic outcome despite antibiotic treatment. Case Reports: A 30-year-old woman with a medical history of active i.v. drug use and tricuspid valve replacement owing to Serratia marcescens endocarditis 2 months prior to presentation was admitted to the Intensive Care Unit for septic shock. The patient did not respond to i.v. fluids and required vasopressors. Blood cultures returned positive for S. marcescens again. The antibiotic regimen consisted of meropenem and vancomycin. The patient underwent redo sternotomy, explant of old tricuspid valve bioprosthesis, debridement of tricuspid valve annulus, and bioprosthetic valve replacement. She continued antibiotic treatment during hospital admission for 6 weeks. In another similar case, a 30-year-old woman, also an i.v. drug user, was admitted to the hospital for tricuspid bioprosthetic valve S. marcescens endocarditis after tricuspid valve replacement 5 months prior to her presentation with S. marcescens endocarditis. Her antibiotic regimen consisted of meropenem and vancomycin. She was eventually transferred to a tertiary cardiovascular surgery center for further case management. Conclusions: In the setting of recurrent bioprosthetic valve S. marcescens endocarditis, it is suggested that treatment should be more focused on source control, including cessation of i.v. drug abuse and providing appropriate antibiotic treatment to prevent recurrence because, in the case of recurrence, morbidity and mortality risk can increase significantly.

Serratia marcescens Endocarditis in Prosthetic Valves

“…Serratia marcescens (S. marcescens) resulting in endocarditis has been described in roughly 70 case reports. A review of the literature showed only one case report of Serratia endocarditis in the prosthetic tricuspid valve due to active intravenous (IV) drug use [1].…”